SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Bought by Marotta Asset Management

Marotta Asset Management raised its holdings in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.0% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 63,196 shares of the exchange traded fund’s stock after acquiring an additional 1,266 shares during the quarter. SPDR S&P Biotech ETF accounts for about 1.2% of Marotta Asset Management’s investment portfolio, making the stock its 24th largest holding. Marotta Asset Management’s holdings in SPDR S&P Biotech ETF were worth $5,784,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in the stock. Fortitude Family Office LLC purchased a new position in SPDR S&P Biotech ETF in the fourth quarter valued at about $117,000. Synovus Financial Corp grew its stake in SPDR S&P Biotech ETF by 110.9% during the 3rd quarter. Synovus Financial Corp now owns 9,391 shares of the exchange traded fund’s stock worth $928,000 after buying an additional 4,939 shares during the last quarter. Sanctuary Advisors LLC lifted its position in SPDR S&P Biotech ETF by 12.7% in the 3rd quarter. Sanctuary Advisors LLC now owns 15,166 shares of the exchange traded fund’s stock valued at $1,460,000 after purchasing an additional 1,711 shares during the last quarter. Pine Valley Investments Ltd Liability Co boosted its stake in SPDR S&P Biotech ETF by 33.0% during the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 10,387 shares of the exchange traded fund’s stock valued at $1,026,000 after purchasing an additional 2,577 shares during the period. Finally, Westside Investment Management Inc. increased its stake in shares of SPDR S&P Biotech ETF by 3.4% in the third quarter. Westside Investment Management Inc. now owns 6,170 shares of the exchange traded fund’s stock valued at $610,000 after purchasing an additional 200 shares during the period.

SPDR S&P Biotech ETF Stock Down 3.0 %

XBI traded down $2.78 during trading on Friday, reaching $89.53. The stock had a trading volume of 3,073,853 shares, compared to its average volume of 6,408,390. The stock has a 50 day moving average of $95.67 and a two-hundred day moving average of $97.09. The firm has a market capitalization of $6.82 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1-year low of $81.14 and a 1-year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.